retatrutide clinical trial dosages phase 2 duration weight loss What the trials say about RETA dosing & (phase data) (clarification for those asking) : retatrutide trial phase dose: the

Holman RR, Bethel MA, Mentz RJ et al (2017) Effects of once-weekly exenatide on cardiovascular outcomes in type 2 diabetes

In fact, the opposite is usually true

SURMOUNT-5 Trial Results This Phase 3b, open-label trial randomized 751 adults with obesity (but without diabetes) to receive either: Maximum tolerated dose of tirzepatide (10 mg or 15 mg) Maximum tolerated dose of semaglutide (1.7 mg or 2.4 mg) Key findings at 72 weeks: The trial concluded that tirzepatide was superior to semaglutide with respect to reduction in body weight and waist circumference at week 72

The rise in popularity has led to a rise in counterfeits pills sold online that may be unregulated, contaminated or outright fake